SPG7 Antikörper (AA 300-573)
Kurzübersicht für SPG7 Antikörper (AA 300-573) (ABIN2152108)
Target
Alle SPG7 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 300-573
-
Aufreinigung
- SPG7 antibody was purified by affinity chromatography.
-
Immunogen
- SPG7 antibody was raised in Mouse using Human recombinant protein fragment corresponding to amino acids 300-573 of human SPG7 prodduced in E.coli as the immunogen.
-
Isotyp
- IgG2a
-
-
-
-
Applikationshinweise
- FC: 1:100, IF: 1:50-100, WB: 1:500-2000
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- In PBS buffer, pH 7.3, containg 1 % BSA, 50 % glycerol and 0.02 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freeze/thaw cycles
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at 4 °C for short term storage. Aliquot and store at -20 °C for long term storage.
-
-
- SPG7 (Spastic Paraplegia 7 (SPG7))
-
Andere Bezeichnung
- SPG7
Target
-